Open House Originale Rabattverträge 2024-08 - Fluticason/Vilanterol

Techniker Krankenkasse·Hamburg, Germany·Deadline Sep 30, 2026 · 37 days left·Open·Supplies

Registrieren zum Speichern Open documents

Structured notice only

Originaltitel der Bekanntmachung

Germany – Pharmaceutical products – Open House Originale Rabattverträge 2024-08 - Fluticason/Vilanterol (Wirkstoffkombination)

50/100

Opportunity Score

Needs reviewLow complexity

SuppliesOpen

Warum diese Bewertung?

Chance

50 / 100

Komplexität

20 / 100

Risikofaktoren

No estimated value or volume is provided. The financial potential of the contract is unknown, complicating bid/no-bid d...

The contract ends automatically on patent expiry. If the patent expires early, the contract may be shorter than expecte...

Tiefe Portfolioanalyse

Tiefe Analyse der Unternehmenspassung

Verwendet:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Überblick

Moderate opportunity

Wichtige Fakten

Supplies contract
1 lot
Duration until Sep 2026
Conclusion of discount contracts for the active ingredient combination Fluticason/Vilanterol
Contracts with uniform conditions, no individual negotiations

Vollständige Zusammenfassung anzeigen

Open House procedure by Techniker Krankenkasse (TK) and other German health insurers to conclude discount contracts (Rabattverträge) for the active ingredient combination Fluticason/Vilanterol. The procedure is non-competitive: any eligible pharmaceutical entrepreneur can join at any time during the contract period (until 30 Sept 2026). No estimated value, no award criteria (all accepted). Eligibility focuses on being a pharmaceutical entrepreneur with proper marketing authorization. The notice clarifies this is not a public procurement subject to EU directives.

Risiken

No estimated value or volume is provided. The financial potential of the contract is unknown, complicating bid/no-bid d...

The contract ends automatically on patent expiry. If the patent expires early, the contract may be shorter than expecte...

Analyse kann unvollständig sein

Nur ein Teil der Vergabeunterlagen wurde analysiert. Weitere Anforderungen, Zertifikate oder Einreichungsdokumente können in den übrigen Unterlagen enthalten sein.

Wichtige Anforderungen

Technical

Must be a pharmaceutical entrepreneur as per § 4 Abs. 18 AMG regarding the offered medicines
Must have a valid marketing authorization for the product in Germany/EU/EEA
No convictions for certain criminal or economic offenses (last 5 years for §123 GWB, last 3 years for §124 GWB)

Anforderungen können unvollständig sein.

Zuschlagskriterien

Lot 1

No award criteria; all eligible participants are accepted.

Auftraggeber

Name

Techniker Krankenkasse

Ort

Hamburg, DEU

E-Mail

[email protected]

Website

www.tk.de/vergabe

Kennung

992-80116-93

Tätigkeit

Health

Lose (1)

LOT-0001